Inspire Medical Systems Inc (INSP)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 53,509 33,048 6,011 -15,734 -21,153 -32,766 -41,073 -43,611 -44,881 -50,422 -43,922 -42,520 -42,042 -47,135 -47,173 -57,174 -57,203 -58,799 -56,661 -41,222
Total stockholders’ equity US$ in thousands 689,695 696,562 638,071 589,024 572,514 544,180 529,359 504,648 496,008 470,204 226,984 225,055 229,048 220,300 219,914 223,131 229,747 228,823 233,594 127,403
ROE 7.76% 4.74% 0.94% -2.67% -3.69% -6.02% -7.76% -8.64% -9.05% -10.72% -19.35% -18.89% -18.36% -21.40% -21.45% -25.62% -24.90% -25.70% -24.26% -32.36%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $53,509K ÷ $689,695K
= 7.76%

Inspire Medical Systems Inc's return on equity (ROE) has shown a consistent improvement over the analyzed periods from March 31, 2020, to December 31, 2024. The company started with a negative ROE of -32.36% in March 2020, indicating that the company was not generating sustainable profits relative to its shareholder equity.

However, there was a gradual improvement in ROE performance, with negative ROE figures decreasing quarter by quarter. By June 30, 2024, Inspire Medical Systems Inc achieved a positive ROE of 0.94%, signaling an improvement in the company's efficiency in utilizing shareholder equity to generate profits.

This positive trend further continued, with the ROE increasing to 7.76% by December 31, 2024, indicating that the company's profitability relative to its shareholder investment improved significantly over the analyzed period. This upward trajectory in ROE suggests that Inspire Medical Systems Inc has been able to enhance its profitability and operational efficiency, which may be positively received by investors and stakeholders.